GOG-102 Study

The GOG-102 Study was a clinical trial that investigated the effectiveness and safety of different treatment options for patients with advanced ovarian cancer. Researchers compared standard chemotherapy with additional targeted therapies to see which approach improved survival rates and reduced side effects. The study aimed to identify the most effective and tolerable treatments to enhance outcomes for patients facing this serious illness. By systematically analyzing patient responses, the trial informs clinical guidelines and helps physicians personalize care based on evidence.